Healthcare provider profile · identity verified

Jerry Todd Thompson, DO

Family Practice · CEDARTOWN, GA · NPI 1659869634

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	375	129
Lisinopril	Lisinopril	348	108
Gabapentin	Gabapentin	337	97
Amlodipine Besylate	Amlodipine Besylate	301	108
Alprazolam	Alprazolam	296	46
Albuterol Sulfate Hfa	Albuterol Sulfate	221	85
Levothyroxine Sodium	Levothyroxine Sodium	213	68
Omeprazole	Omeprazole	191	69
Pantoprazole Sodium	Pantoprazole Sodium	191	62
Furosemide	Furosemide	149	52
Clonazepam	Clonazepam	135	20
Trazodone Hcl	Trazodone Hcl	126	44
Rosuvastatin Calcium	Rosuvastatin Calcium	125	46
Montelukast Sodium	Montelukast Sodium	123	43
Metformin Hcl	Metformin Hcl	121	44
Eliquis	Apixaban	120	23
Potassium Chloride	Potassium Chloride	115	43
Carvedilol	Carvedilol	110	34
Fluticasone Propionate	Fluticasone Propionate	109	50
Metoprolol Tartrate	Metoprolol Tartrate	106	35
Metoprolol Succinate	Metoprolol Succinate	105	37
Tamsulosin Hcl	Tamsulosin Hcl	98	30
Zolpidem Tartrate	Zolpidem Tartrate	98	16
Losartan Potassium	Losartan Potassium	96	35
Escitalopram Oxalate	Escitalopram Oxalate	95	37
Buspirone Hcl	Buspirone Hcl	90	22
Famotidine	Famotidine	90	27
Methylprednisolone	Methylprednisolone	89	78
Tizanidine Hcl	Tizanidine Hcl	85	14
Meloxicam	Meloxicam	80	37
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	77	19
Sertraline Hcl	Sertraline Hcl	75	29
Symbicort	Budesonide/Formoterol Fumarate	73	24
Ondansetron Odt	Ondansetron	72	33
Mounjaro	Tirzepatide	69	suppressed
Duloxetine Hcl	Duloxetine Hcl	67	22
Fluoxetine Hcl	Fluoxetine Hcl	67	22
Citalopram Hbr	Citalopram Hydrobromide	65	23
Fenofibrate	Fenofibrate	62	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	62	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	61	17
Pravastatin Sodium	Pravastatin Sodium	61	20
Simvastatin	Simvastatin	61	20
Ropinirole Hcl	Ropinirole Hcl	60	16
Cefdinir	Cefdinir	55	41
Clopidogrel	Clopidogrel Bisulfate	54	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	54	16
Meclizine Hcl	Meclizine Hcl	54	24
Bupropion Xl	Bupropion Hcl	51	18
Hydrochlorothiazide	Hydrochlorothiazide	51	20
Ozempic	Semaglutide	48	suppressed
Spironolactone	Spironolactone	48	20
Tramadol Hcl	Tramadol Hcl	48	20
Methocarbamol	Methocarbamol	46	26
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	44	23
Jardiance	Empagliflozin	44	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	43	38
Glipizide Er	Glipizide	43	12
Ibuprofen	Ibuprofen	43	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	42	12
Lorazepam	Lorazepam	42	suppressed
Pregabalin	Pregabalin	42	12
Allopurinol	Allopurinol	41	15
Nifedipine Er	Nifedipine	41	suppressed
Diclofenac Sodium	Diclofenac Sodium	40	12
Venlafaxine Hcl Er	Venlafaxine Hcl	40	11
Sumatriptan Succinate	Sumatriptan Succinate	38	suppressed
Ezetimibe	Ezetimibe	36	13
Prednisone	Prednisone	36	28
Ventolin Hfa	Albuterol Sulfate	36	14
Azithromycin	Azithromycin	35	34
Atenolol	Atenolol	33	suppressed
Paroxetine Hcl	Paroxetine Hcl	33	12
Hydralazine Hcl	Hydralazine Hcl	32	11
Fenofibrate	Fenofibrate Nanocrystallized	31	suppressed
Donepezil Hcl	Donepezil Hcl	30	13
Oxybutynin Chloride	Oxybutynin Chloride	30	suppressed
Promethazine Hcl	Promethazine Hcl	30	11
Valacyclovir	Valacyclovir Hcl	30	13
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	29	12
Estradiol	Estradiol	29	suppressed
Temazepam	Temazepam	28	suppressed
Warfarin Sodium	Warfarin Sodium	28	suppressed
Alendronate Sodium	Alendronate Sodium	27	suppressed
Diazepam	Diazepam	27	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Valsartan	Valsartan	27	suppressed
Farxiga	Dapagliflozin Propanediol	26	suppressed
Myrbetriq	Mirabegron	26	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	25	suppressed
Fluconazole	Fluconazole	25	18
Hydroxyzine Pamoate	Hydroxyzine Pamoate	25	11
Dicyclomine Hcl	Dicyclomine Hcl	24	suppressed
Mirtazapine	Mirtazapine	24	11
Triamcinolone Acetonide	Triamcinolone Acetonide	24	17
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Metformin Hcl Er	Metformin Hcl	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Glipizide	Glipizide	21	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Novolog Flexpen	Insulin Aspart	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Sucralfate	Sucralfate	19	suppressed
Amantadine	Amantadine Hcl	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	17	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	17	17
Januvia	Sitagliptin Phosphate	17	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	17	suppressed
Aripiprazole	Aripiprazole	16	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Memantine Hcl	Memantine Hcl	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Linzess	Linaclotide	15	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	15	suppressed
Ranolazine Er	Ranolazine	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	11
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Topiramate	Topiramate	14	suppressed
Colestipol Hcl	Colestipol Hcl	13	suppressed
Finasteride	Finasteride	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Mupirocin	Mupirocin	13	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	13
Tradjenta	Linagliptin	13	suppressed
Brilinta	Ticagrelor	12	suppressed
Creon	Lipase/Protease/Amylase	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Celecoxib	Celecoxib	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Nystatin	Nystatin	11	suppressed
Risperidone	Risperidone	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error